Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mayo Clinic
Age
40–80
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
\- Past prior screening mammogram within the previous 11-24 months interpreted as heterogeneously dense or extremely dense and negative or benign \[Breast Imaging Reporting and Data System (BI-RADS) Category 1 or 2\]
You may not be if
Subjects will be excluded if they:
Are unable to understand and sign the consent form
Are pregnant or lactating
Are physically unable to sit upright and still for 40 minutes
Have self-reported signs or symptoms that may suggest breast cancer (palpable mass, bloody nipple discharge, axillary mass, etc.)
Have had needle biopsy within 3 months, or breast surgery or radiation within 1 year prior to the study
Are currently receiving chemotherapy or tamoxifen, raloxifene, or an aromatase inhibitor for adjuvant therapy or chemoprevention
Have undergone bilateral mastectomy
Have had a prior MBI within 20 months of scheduled study MBI.
Clareo Health | Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up
